Facts
The TA (Tennis Australia) reported an anti-doping violation against Bradly Mousley. During a Match on March 30, 2014, a sample was taken for doping control purposes. Analysis of the sample showed the presence of methylenedioxymethamphetamine (MDMA) and its metabolite methlenedioxyamphetamine (MDA) which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.
History
Mousley admitted taking ecstasy at a party in March, he didn't had the intension to enhance his sport performance.
Decision
The Tennis Australia Anti-Doping Tribunal imposed a one year ban to commence on 30 May 2014 (when a period of provisional suspension was imposed on him by Tennis Australia pursuant to Article 17 of the Policy) and to conclude on 29 May 2015. During the suspension period Mr Mousley is ineligible to participate, as an athlete or support person in any sports that have adopted a World Anti-Doping Agency compliant anti-doping policy. Further any results and any points obtained by Mr Mousley in the ITF F4 Futures Pro Series Tournament played in Melbourne (Australia) between March 30, 2014 and April, 6 2014 are to be forfeited and Mr. Mousley is to return to the ITF any medal or prize received by him. Further all competitive results obtained by Mr, Mousley from March 30, 2014 (date the positive sample was collected) until May 30, 2014 (date of provisional suspension) are to be forfeited.